Skip to main content

Clover Health Investments, Corp.

CLOV
Exchange
Nasdaq
Industry
Hospital & Medical Service Plans
SEC CIK
0001801170

In the last 90 days, Clover Health Investments, Corp. insiders filed 0 open-market purchases and 18 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $762.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Clover Health Investments, Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
18 filings
6 insiders, $4.61M in total
Insiders trading
6
Net value
−$4.61M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Clover Health Investments, Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Clover Health Investments, Corp.
NameTitleLast reported holdingLast filingFilings, past year
Reynoso Jamie L.CEO, Medicare Advantage2,803,446Sep 18, 202624
Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER275,897Sep 17, 20263
Wai ConradCEO, Counterpart Health1,170,056IndirectSep 16, 202610
Soares KarenChief Legal Officer1,607,371Sep 15, 202614
Thornton Joseph ClayInterim CFO1,249,526Aug 17, 20265
Toy AndrewChief Executive Officer9,459,316Aug 10, 202612
Edwards Carladenise ArmbristerDirector285,432May 19, 20262
Priest Brady PatrickCEO of Clover Care Services2,040,222May 13, 20269
Kuipers Peter J.Chief Financial Officer5,758,353Feb 2, 20262
Garipalli VivekDirector, 10% Owner1,856,247Jan 9, 20261
Tran Thomas LDirector180,029Jan 8, 20261
Robinson William G JrDirector597,987Jan 8, 20261
Kouzoukas Demetrios L.Director605,980Jan 8, 20261
Loengard Anna UDirector527,456Jan 8, 20261
Shapiro LeeDirector598,622Jan 8, 20250
Clinton ChelseaDirector602,814Jan 8, 20250
Sharp Aric RCEO of Value Based Care2,100,665Aug 13, 20240
Leffler Scott J.Chief Financial Officer4,857,303Jan 29, 20240
Clover Health Investments, Corp.Chief Technology Officer3,093,225Nov 2, 20230
Martin Joseph RichardsGeneral Counsel2,718,857Jun 16, 20230
Singh PrabhdeepChief Growth Officer872,821Sep 20, 20220
Turner Nathaniel S.Director–Feb 22, 20220
Palihapitiya Chamath10% Owner, Other: See Remarks1,739,130IndirectNov 24, 20210
SCH Sponsor III LLC10% Owner, Other: Former Director1,739,130IndirectNov 24, 20210
ChaChaCha SPAC C, LLC10% Owner, Other: Former Director1,739,130IndirectNov 24, 20210
Peretz Benjamin10% Owner–Nov 24, 20210
Greenoaks Capital Partners LLC10% Owner, Other: See Remarks–Nov 24, 20210
Mehta Neil10% Owner–Nov 24, 20210
Wagner Joseph F.Chief Financial Officer25,000Aug 11, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2026 (view filing)4:22 PM ETSep 171 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−1.92K$4.56−$8.76K−0.1%2.80M after10b5-1
Sep 17, 2026 (view filing)5:29 PM ETSep 161 dayOldakowski Joseph FrankVP OF FINANCE AND CONTROLLERSSaleClass A Common Stock−3.17K$4.64−$14.7K−1.1%275.9K after10b5-1
Sep 16, 2026 (view filing)4:27 PM ETSep 151 dayWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−300.0K$4.72−$1.42M−20.4%1.17M after10b5-1
Sep 15, 2026 (view filing)8:11 PM ETSep 15Same daySoares KarenChief Legal OfficerSSaleClass A Common Stock−6.85K$4.78−$32.7K−0.4%1.61M after10b5-1
Sep 15, 2026 (view filing)7:48 PM ETSep 15Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−9.27K$4.78−$44.3K−0.3%2.81M after10b5-1
Sep 14, 2026 (view filing)8:52 PM ETSep 14Same dayOldakowski Joseph FrankVP OF FINANCE AND CONTROLLERSSaleClass A Common Stock−20.0K$5.16−$103.2K−6.7%279.1K after
Aug 17, 2026 (view filing)5:58 PM ETAug 17Same dayThornton Joseph ClayInterim CFOSSaleClass A Common Stock−17.8K$4.39−$78.0K−1.4%1.25M after10b5-1
Aug 10, 2026 (view filing)6:30 PM ETAug 10Same dayToy AndrewChief Executive OfficerSSaleClass A Common Stock−87.8K$4.65−$408.3K−0.9%9.46M after10b5-1
Jul 20, 2026 (view filing)5:48 PM ETJul 20Same daySoares KarenChief Legal OfficerSSaleClass A Common Stock−51.7K$4.51−$233.2K−3.3%1.51M after10b5-1
Jul 17, 2026 (view filing)5:26 PM ETJul 17Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−4.84K$4.53−$21.9K−0.2%2.81M after10b5-1
Jul 16, 2026 (view filing)4:59 PM ETJul 151 dayToy AndrewChief Executive OfficerSSaleClass A Common Stock−62.7K$4.67−$292.9K−0.7%9.55M after10b5-1
Jul 16, 2026 (view filing)4:55 PM ETJul 151 dayWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−24.2K$4.67−$113.1K−2.1%1.15M after10b5-1
Jul 16, 2026 (view filing)4:50 PM ETJul 151 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−13.1K$4.67−$61.3K−0.5%2.82M after10b5-1
Jul 16, 2026 (view filing)4:44 PM ETJul 151 daySoares KarenChief Legal OfficerSSaleClass A Common Stock−10.5K$4.67−$49.1K−0.7%1.56M after10b5-1
Jul 16, 2026 (view filing)4:42 PM ETJul 151 dayThornton Joseph ClayInterim CFOSSaleClass A Common Stock−4.63K$4.67−$21.6K−0.4%1.21M after10b5-1
Jul 9, 2026 (view filing)4:45 PM ETJul 81 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−2.38K$4.68−$11.2K−0.1%2.83M after10b5-1
Jul 6, 2026 (view filing)5:57 PM ETJul 6Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−6.23K$5.26−$32.8K−0.2%2.83M after10b5-1
Jul 1, 2026 (view filing)6:33 PM ETJul 1Same dayToy AndrewChief Executive OfficerSSaleClass A Common Stock−313.5K$5.32−$1.67M−3.2%9.61M after10b5-1
Jun 18, 2026 (view filing)Jun 171 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−2.36K$4.78−$11.3K−0.1%2.84M after10b5-1
Jun 17, 2026 (view filing)Jun 161 dayOldakowski Joseph FrankVP OF FINANCE AND CONTROLLERSSaleClass A Common Stock−12.1K$4.86−$58.8K−3.9%299.1K after10b5-1
Jun 16, 2026 (view filing)Jun 151 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−6.35K$4.61−$29.3K−0.2%2.84M after10b5-1
Jun 16, 2026 (view filing)Jun 151 daySoares KarenChief Legal OfficerSSaleClass A Common Stock−4.68K$4.61−$21.6K−0.3%1.57M after10b5-1
Jun 11, 2026 (view filing)Jun 11Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−7.29K$4.91−$35.8K−0.3%2.85M after10b5-1
May 28, 2026 (view filing)May 28Same dayWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−220.4K$3.99−$879.5K−13.7%1.39M after10b5-1
May 19, 2026 (view filing)May 181 dayEdwards Carladenise ArmbristerDirectorSSaleClass A Common Stock−67.2K$3.42−$229.7K−19.0%285.4K after
May 13, 2026 (view filing)May 13Same dayPriest Brady PatrickCEO of Clover Care ServicesSSaleClass A Common Stock−98.0K$3.52−$345.1K−4.6%2.04M after
Mar 18, 2026 (view filing)Mar 18Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−5.83K$1.91−$11.1K−0.2%2.72M after10b5-1
Mar 5, 2026 (view filing)Mar 41 dayPriest Brady PatrickCEO of Home CareSSaleClass A Common Stock−175.0K$2.17−$379.8K−8.1%2.00M after
Jan 20, 2026 (view filing)Jan 20Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−4.60K$2.58−$11.9K−0.2%2.74M after10b5-1
Jan 7, 2026 (view filing)Jan 7Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−2.10K$2.53−$5.32K−0.1%2.76M after10b5-1
Dec 18, 2025 (view filing)Dec 18Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−4.91K$2.61−$12.8K−0.2%2.77M after10b5-1
Nov 5, 2025 (view filing)Nov 41 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−30.4K$3.58−$108.8K−1.1%2.79M after10b5-1
Oct 21, 2025 (view filing)Oct 174 daysReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−16.5K$2.69−$44.4K−0.6%2.96M after10b5-1
Oct 7, 2025 (view filing)Oct 7Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−2.01K$2.65−$5.33K−0.1%3.04M after10b5-1
Sep 19, 2025 (view filing)Sep 172 daysReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−4.91K$3.09−$15.2K−0.2%3.05M after10b5-1
Aug 14, 2025 (view filing)Aug 131 dayLoengard Anna UDirectorPPurchaseClass A Common Stock+26.5K$2.59+$68.8K+852.1%29.6K after2 lots
Aug 8, 2025 (view filing)Aug 7-81 dayGaripalli VivekDirector, 10% OwnerPPurchaseClass A Common Stock+447.0K$2.23+$999.0K+31.7%1.86M after2 lots
Aug 6, 2025 (view filing)Aug 42 daysReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−6.82K$2.89−$19.7K−0.2%3.26M after10b5-1
Jul 24, 2025 (view filing)Jul 22-232 daysWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−209.8K$3.30−$693.0K−13.0%1.40M after2 lots10b5-1
Jul 10, 2025 (view filing)Jul 82 daysWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−15.2K$3.26−$49.6K−0.9%1.61M afterAmended10b5-1
Jul 8, 2025 (view filing)Jul 3-75 daysReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−21.8K$2.60−$56.8K−0.7%3.30M after2 lots10b5-1
Jun 18, 2025 (view filing)Jun 171 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−20.4K$2.86−$58.5K−0.6%3.20M after10b5-1
Mar 11, 2025 (view filing)Mar 74 daysEdwards Carladenise ArmbristerDirectorSSaleClass A Common Stock−200.0K$3.61−$722.0K−42.3%273.2K after
Mar 7, 2025 (view filing)Mar 61 dayPriest Brady PatrickCEO of Home CareSSaleClass A Common Stock−75.0K$3.68−$276.0K−3.0%2.42M after
Mar 7, 2025 (view filing)Mar 61 daySoares KarenGeneral Counsel & SecretarySSaleClass A Common Stock−52.5K$3.80−$199.5K−3.9%1.30M after
Aug 13, 2024 (view filing)Aug 94 daysGaripalli VivekDirector, 10% OwnerPPurchaseClass A Common Stock+531.7K$1.88+$999.6K+60.6%1.41M after
Jun 20, 2024 (view filing)Jun 173 daysGaripalli VivekDirector, 10% OwnerPPurchaseClass A Common Stock+877.6K$1.14+$1.00MNew position877.6K after
May 20, 2024 (view filing)May 16-174 daysLoengard Anna UDirectorPPurchaseClass A Common Stock+27.1K$0.9478+$25.7KNew position15.1K after3 lots
Mar 18, 2024 (view filing)Mar 144 daysLoengard Anna UDirectorPPurchaseClass A Common Stock+137.0K$0.73+$100.0K+34.1%538.8K after
Mar 18, 2024 (view filing)Mar 144 daysLoengard Anna UDirectorPPurchaseClass A Common Stock+13.6K$0.73+$9.95K+908.3%15.1K after